Related Experiment Videos
Characterization of a Helicobacter pylori vaccine candidate by proteome techniques
1Genelabs Technologies, Redwood City, CA 94063, USA.
Abstract:
In a previous two-dimensional (2D) gel electrophoretic study of protein antigens of the gastric pathogen, Helicobacter pylori recognized by human sera, one of the highly and consistently reactive antigens, a protein with Mr of approximately 30,000 (Spot 15) seemed to be of special interest because of low yields on N-terminal protein sequencing. This suggested possible N-terminal modification, as the N-terminal sequence analysis of this 30,000 protein (Spot 15) did not provide a definitive match within the H. pylori genomic database. This protein was isolated by 2D polyacrylamide gel electrophoresis, evaluated by liquid chromatography-mass spectrometry, and found to consist of two related species of approximately 28,100 and 26,500. In parallel, the proteins within this spot were digested in situ with the endoprotease Lys-C. Analysis of the Lys-C digest by matrix-assisted laser desorption time-of-flight mass spectrometry, peptide mapping, and sequence analysis was conducted. Comparison of the mass and sequence of the Lys-C peptides with those derived from a H. pylori genomic library identified an open reading frame of approximately 300 base pairs as the source of the Spot 15 protein. This corresponded to HP0175 in the recently reported H. pylori genome sequence, an open reading frame with some homology to Campylobacter jejeuni cell binding protein 2. Mass spectral and sequence analysis indicated that Spot 15 was a processed product generated by proteolytic cleavage at both the carboxy and amino termini of the 34 open reading frame precursor.
Insights
Researchers identified a Helicobacter pylori protein (Spot 15) using mass spectrometry. This antigen is a processed product of the HP0175 gene, resulting from cleavage of its precursor.
Area of Science:
- Microbiology
- Proteomics
- Molecular Biology
Background:
- Helicobacter pylori is a gastric pathogen.
- Previous studies identified a 30,000 MW protein (Spot 15) recognized by human sera.
- N-terminal sequencing challenges suggested possible protein modification.
Purpose of the Study:
- To identify the source and nature of the H. pylori Spot 15 protein.
- To investigate the N-terminal modification suggested by previous sequencing.
Main Methods:
- Two-dimensional polyacrylamide gel electrophoresis (2D PAGE) for protein isolation.
- Liquid chromatography-mass spectrometry (LC-MS) for initial evaluation.
- In situ endoprotease Lys-C digestion followed by matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF MS) and peptide sequencing.
- Comparison of peptide data with the H. pylori genomic database.
Main Results:
- Spot 15 consists of two related species (approx. 28,100 and 26,500 MW).
- Peptide analysis identified the source as an open reading frame (ORF) corresponding to HP0175.
- HP0175 has homology to Campylobacter jejuni cell binding protein 2.
- Spot 15 is a processed product resulting from proteolytic cleavage at both termini of the HP0175 precursor protein.
Conclusions:
- The H. pylori Spot 15 antigen is a processed form of the protein encoded by the HP0175 gene.
- Proteolytic cleavage generates the mature Spot 15 protein from its precursor.
- This finding clarifies the identity of a significant H. pylori antigen.